What Is End-Stage Renal Disease?

End-Stage Renal Disease (ESRD) refers to the final stage of chronic kidney disease (CKD), when the kidneys can no longer perform their essential functions to sustain life. At this stage, the kidneys have lost nearly all of their filtering ability—typically more than 85 to 90 percent of function—and are no longer able to remove waste, excess fluids, or electrolytes from the bloodstream effectively. As a result, individuals with ESRD require long-term renal replacement therapy, which includes dialysis or a kidney transplant, to survive.

ESRD is considered a permanent condition. While treatments can help manage the symptoms and extend life expectancy, there is no cure except for a successful kidney transplant. This stage marks a point at which earlier interventions for CKD are no longer sufficient to maintain the body’s internal balance.

Causes and Risk Factors

The progression to ESRD is often the result of long-standing damage from chronic health conditions. The most common causes include:

• Diabetes mellitus, particularly type 2 diabetes, which over time can damage the nephrons (filtering units of the kidney) due to high blood sugar levels.
• Hypertension (high blood pressure), which exerts pressure on the blood vessels of the kidneys, impairing their ability to function properly.
• Glomerulonephritis, a group of diseases that cause inflammation of the kidney's filtering units.
• Polycystic kidney disease, a genetic disorder that leads to the formation of fluid-filled cysts in the kidneys.
• Prolonged obstruction of the urinary tract from conditions like kidney stones or enlarged prostate.

Other contributors may include recurrent kidney infections, certain autoimmune diseases (such as lupus), or long-term use of medications that harm the kidneys.

Lifestyle, genetic predisposition, socioeconomic factors, and access to healthcare also play a role in determining who is at greater risk of progressing to ESRD.

Symptoms and Diagnosis

Symptoms of ESRD typically develop as kidney function declines and toxins begin to accumulate in the blood. Common signs include fatigue, swelling in the legs or ankles (edema), shortness of breath, nausea, vomiting, loss of appetite, confusion, muscle cramps, and changes in urination patterns.

Diagnosis is based on a combination of clinical evaluation, medical history, lab tests, and imaging studies. Key indicators include:

• Estimated glomerular filtration rate (eGFR) consistently below 15 mL/min/1.73 m².
• Elevated levels of blood urea nitrogen (BUN) and creatinine, which are waste products normally cleared by the kidneys.
• Electrolyte imbalances, such as elevated potassium or phosphate levels.
• Urinalysis showing proteinuria or hematuria.
• Kidney ultrasound or other imaging showing structural changes.

Once ESRD is confirmed, treatment planning begins immediately to initiate renal replacement therapy.

Treatment Options

Because ESRD involves irreversible kidney failure, treatment focuses on replacing the lost kidney function and managing complications. The two primary forms of renal replacement therapy are:

Dialysis
This includes both hemodialysis and peritoneal dialysis. Hemodialysis uses a machine to filter the blood externally, usually three times per week at a clinic or hospital. Peritoneal dialysis involves instilling a special solution into the abdominal cavity via a catheter, using the lining of the abdomen to filter waste.

Kidney Transplant
This is often considered the preferred treatment, as it can offer a better quality of life and longer survival compared to long-term dialysis. Transplants may come from a living or deceased donor, but not all patients are candidates due to age, other medical conditions, or availability of organs.

In addition to these therapies, treatment typically includes medications to manage blood pressure, anemia, bone disease, and electrolyte imbalances. Dietary adjustments are also essential, especially with regard to sodium, potassium, phosphorus, and fluid intake.

Prognosis and Life Impact

Living with ESRD has significant medical, emotional, and financial implications. Patients undergoing dialysis may experience fatigue, dietary restrictions, and disruptions to their daily routine. Those awaiting or recovering from a transplant face their own set of challenges, including immunosuppressive therapy and potential complications.

Life expectancy varies widely and depends on age, underlying conditions, treatment adherence, and access to care. With effective treatment and management, many individuals with ESRD can live for years, though the condition requires lifelong monitoring and support.

Medicare and ESRD

In the United States, individuals with ESRD are eligible for Medicare coverage regardless of age, a unique provision reflecting the critical nature of the condition and the high cost of treatment. Coverage typically includes dialysis, kidney transplant services, and related care, though certain conditions apply based on the type of treatment chosen and other insurance status.

The Bottom Line

End-Stage Renal Disease is the final and most severe stage of chronic kidney disease, marked by the near-total loss of kidney function. Without dialysis or a transplant, it is life-threatening. While modern treatment options can extend life and manage symptoms, ESRD is a permanent condition that requires ongoing medical intervention and lifestyle adjustment. Early detection and management of conditions like diabetes and hypertension remain the most effective ways to prevent progression to this stage.